tiprankstipranks
Trending News
More News >
iX Biopharma Ltd. (SG:42C)
SGX:42C
Singapore Market

iX Biopharma Ltd. (42C) Ratios

Compare
13 Followers

iX Biopharma Ltd. Ratios

SG:42C's free cash flow for Q4 2024 was S$0.30. For the 2024 fiscal year, SG:42C's free cash flow was decreased by S$ and operating cash flow was S$-0.66. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
1.05 0.47 0.89 1.53 2.14
Quick Ratio
0.94 0.37 0.71 1.40 2.03
Cash Ratio
0.72 0.10 0.24 0.91 1.72
Solvency Ratio
-0.83 -0.85 -0.97 -0.96 -0.40
Operating Cash Flow Ratio
-0.47 -0.42 -0.89 -1.07 0.40
Short-Term Operating Cash Flow Coverage
-1.31 -0.92 -2.63 -2.78 0.95
Net Current Asset Value
S$ -3.35MS$ -6.71MS$ -3.70MS$ 1.90MS$ 8.07M
Leverage Ratios
Debt-to-Assets Ratio
0.42 0.52 0.36 0.17 0.15
Debt-to-Equity Ratio
1.63 16.17 1.20 0.27 0.22
Debt-to-Capital Ratio
0.62 0.94 0.55 0.21 0.18
Long-Term Debt-to-Capital Ratio
0.44 0.80 0.33 0.03 0.04
Financial Leverage Ratio
3.84 30.92 3.37 1.57 1.44
Debt Service Coverage Ratio
-1.85 -2.04 -3.24 -2.78 -0.96
Interest Coverage Ratio
-20.08 -19.58 -16.71 -31.04 6.14
Debt to Market Cap
0.03 0.40 0.21 0.05 0.03
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
-0.16 -0.56 -0.40 0.26 3.20
Profitability Margins
Gross Profit Margin
26.26%26.26%17.59%39.24%85.41%
EBIT Margin
-80.92%-126.42%-160.14%-159.56%-27.08%
EBITDA Margin
-75.59%-115.42%-145.58%-143.85%-19.72%
Operating Profit Margin
-80.92%-80.92%-123.98%-142.25%8.62%
Pretax Profit Margin
-130.55%-130.55%-167.56%-164.15%-28.49%
Net Profit Margin
-130.57%-130.57%-181.14%-162.61%-31.95%
Continuous Operations Profit Margin
-130.57%-130.57%-181.14%-162.61%-31.95%
Net Income Per EBT
100.01%100.01%108.10%99.06%112.17%
EBT Per EBIT
161.34%161.34%135.15%115.40%-330.56%
Return on Assets (ROA)
-63.84%-89.87%-73.81%-38.57%-16.12%
Return on Equity (ROE)
-450.81%-2778.36%-248.71%-60.65%-23.29%
Return on Capital Employed (ROCE)
-79.34%-272.67%-102.00%-47.38%6.00%
Return on Invested Capital (ROIC)
-56.28%-94.36%-73.00%-39.78%5.13%
Return on Tangible Assets
-64.89%-92.07%-75.33%-39.03%-16.32%
Earnings Yield
-5.48%-72.50%-48.50%-13.81%-3.74%
Efficiency Ratios
Receivables Turnover
5.38 4.01 4.40 4.37 25.93
Payables Turnover
1.30 1.33 3.90 9.10 9.38
Inventory Turnover
6.50 6.21 3.56 3.76 2.32
Fixed Asset Turnover
1.10 1.16 0.78 0.72 1.86
Asset Turnover
0.49 0.69 0.41 0.24 0.50
Working Capital Turnover Ratio
-3.58 -2.79 3.96 0.92 1.96
Cash Conversion Cycle
-155.84 -125.11 91.85 140.57 132.62
Days of Sales Outstanding
67.86 91.07 82.94 83.58 14.08
Days of Inventory Outstanding
56.15 58.76 102.57 97.12 157.47
Days of Payables Outstanding
279.85 274.94 93.65 40.13 38.93
Operating Cycle
124.01 149.84 185.50 180.70 171.55
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 >-0.01 >-0.01 -0.01 <0.01
Free Cash Flow Per Share
>-0.01 >-0.01 >-0.01 -0.01 <0.01
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.05 1.05 1.04 1.09 0.94
Dividend Paid and CapEx Coverage Ratio
-18.70 -18.70 -22.99 -11.02 15.62
Capital Expenditure Coverage Ratio
-18.70 -18.70 -22.99 -11.02 15.62
Operating Cash Flow Coverage Ratio
-0.56 -0.64 -1.26 -1.77 0.71
Operating Cash Flow to Sales Ratio
-0.48 -0.48 -1.10 -1.30 0.22
Free Cash Flow Yield
-1.82%-28.30%-30.73%-12.00%2.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-17.82 -1.38 -2.06 -7.24 -26.75
Price-to-Sales (P/S) Ratio
27.37 1.80 3.73 11.77 8.55
Price-to-Book (P/B) Ratio
43.71 38.32 5.13 4.39 6.23
Price-to-Free Cash Flow (P/FCF) Ratio
-53.69 -3.53 -3.25 -8.33 42.08
Price-to-Operating Cash Flow Ratio
-48.09 -3.72 -3.40 -9.09 39.39
Price-to-Earnings Growth (PEG) Ratio
-10.51 0.08 -0.17 -0.07 0.55
Price-to-Fair Value
43.71 38.32 5.13 4.39 6.23
Enterprise Value Multiple
-36.37 -2.12 -2.96 -7.93 -40.15
Enterprise Value
218.73M 19.02M 25.68M 67.42M 113.92M
EV to EBITDA
-37.26 -2.12 -2.96 -7.93 -40.15
EV to Sales
28.16 2.45 4.31 11.40 7.92
EV to Free Cash Flow
-55.25 -4.81 -3.76 -8.07 38.97
EV to Operating Cash Flow
-58.20 -5.06 -3.92 -8.80 36.48
Tangible Book Value Per Share
<0.01 <0.01 <0.01 0.02 0.03
Shareholders’ Equity Per Share
<0.01 <0.01 <0.01 0.02 0.03
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 -0.08 <0.01 -0.12
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 0.02
Net Income Per Share
-0.01 -0.01 -0.01 -0.01 >-0.01
Tax Burden
1.00 1.00 1.08 0.99 1.12
Interest Burden
1.61 1.03 1.05 1.03 1.05
Research & Development to Revenue
0.21 0.21 0.29 0.48 0.16
SG&A to Revenue
0.60 0.60 0.72 0.99 0.51
Stock-Based Compensation to Revenue
<0.01 <0.01 -0.14 0.14 0.10
Income Quality
0.37 0.37 0.61 0.80 -0.68
Currency in SGD